Results 101 to 110 of about 140,141 (234)

Phase-shifting of the transmissibility of macrolide-sensitive and resistant Mycoplasma pneumoniae epidemics in Hong Kong, from 2015 to 2018

International Journal of Infectious Diseases, 2019
Mycoplasma pneumoniae is a threat to public health. This pathogen caused an epidemic in Hong Kong during the years 2015–2018. The reproduction number during the initial epidemic was estimated to be 1.7 for macrolide-resistant M. pneumoniae (MRMP) and 1.4
Shi Zhao, Salihu S. Musa, Jing Qin, Daihai He   +3 more
doaj   +1 more source

Mycoplasma Pneumonia [PDF]

Annual Review of Medicine, 1966
B R, Forsyth, R M, Chanock
openaire   +2 more sources

Mycoplasma pneumoniae Infection: An Updated Narrative Review [PDF]

Pneumonia cases in China, which rose sharply from October to November 2023, have received particular attention in the world of health. Chinese authorities said the trigger was not a new pathogen, one of which was Mycoplasma.
Kusuma Wardani, Ni Made Ayu Mulia
core   +1 more source

Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England. [PDF]

, 2006
Guillain-Barré syndrome (GBS) is the most common cause of acute flaccid paralysis in polio-free regions. Considerable evidence links Campylobacter infection with GBS, but evidence that implicates other pathogens as triggers remains scarce. We conducted a
O'Brien, Sarah J, Tam, CC, Sarah J. O’Brien, Laura Rodrigues, Tam, Clarence C, Rodrigues, Laura C, Sarah O'Brien, O'Brien, SJ, Laura C. Rodrigues, Rodrigues, LC., Clarence C. Tam, Clarence Tam   +11 more
core   +1 more source

Taming the Inflammation: The Role of Corticosteroids in Pediatric Mycoplasma Pneumonia

Children
Background/Objectives: To summarize the available evidence on the use of corticosteroids in the treatment of pediatric Mycoplasma pneumoniae pneumonia, including severe and refractory forms.
Maria Sole Valentino, Costanza Pagliani, Chiara Lovati, Roberta Caiazzo, Crescenzo Coppola, Raffaella Di Tonno, Marta Stracuzzi, Vania Giacomet   +7 more
doaj   +1 more source

Biochemical and serological characterization of Mycoplasma from bovine clinical mastitis in southwest and northern Nigeria

, 2010
The primary objective of this study was to isolate and characterize the mycoplasma species present in clinical cases of mastitic cows in Southwest and Northern Nigeria and to determine the prevalence of mycoplasma mastitis in dairy cows. Two hundred milk
Adetosoye, A. I., Amosun, E. A., Ajuwape, A. T. P.   +2 more
core   +1 more source

Chlamydia pneumoniae in atherosclerotic middle cerebral artery [PDF]

, 2001
Background and Purpose—Atherosclerotic middle cerebral arteries are frequent sites of thrombosis, leading to stroke. Previous studies have suggested a role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis.
Virók, Dezső, Intzédy, László, Burián, Katalin, Iványi, Béla, Gönczöl, Éva, Karai, László, Kis, Zoltán, Szabó, Árpád   +7 more
core   +1 more source

Comparison of the clinical characteristics in parents and their children in a series of family clustered Mycoplasma pneumoniae infections

BMC Pulmonary Medicine
Background Mycoplasma pneumoniae infections have increased in China recently, causing some evidence of familial clustering. The purpose of this study was to compare the clinical features of parents and children in cases of familial clustering of ...
Xu Liu, Qingfeng Zhang, Hao Chen, Yueying Hao, Jingyi Zhang, Shiqian Zha, Beini Zhou, Yaohua Yi, Rui Xiao, Ke Hu   +9 more
doaj   +1 more source

The role of the Streptococcus pneumoniae capsule in interactions with complement and phagocytes [PDF]

, 2010
The Streptococcus pneumoniae capsule is an essential virulence factor and it is ideally situated to modulate interactions between the bacteria and host immune cells.
Hyams, C.J.
core  

Clinical performance of two commercial PCR assays for the detection of macrolide resistance in Mycoplasma pneumoniae

Journal of Clinical Microbiology
Macrolides are the first-line treatment for Mycoplasma pneumoniae infections; however, macrolide resistance has been reported. We evaluated the clinical performance of two commercial assays for detecting macrolide-resistant M.
Nadège Hénin, Alicia Silvant, Marie Gardette, Carla Balcon, Jennifer Guiraud, Cécile Bébéar, Sabine Pereyre   +6 more
doaj   +1 more source